Share Issue News
Discover the latest share issue news. Stay informed about new share offerings, market impacts, investor reactions, and financial strategies. Get updates on how share issues influence company valuations and investment opportunities.
Sep 1, 2026 at 5:00 PM
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today announced that on August 31st, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of nonstatutory stock options to purchase 20,000 shares of common stock to...
Sep 1, 2026 at 9:05 AM
American Business Bank Announces Authorization of Third Stock Repurchase Program
LOS ANGELES--(BUSINESS WIRE)--AMERICAN BUSINESS BANK ANNOUNCES AUTHORIZATION OF THIRD STOCK REPURCHASE PROGRAM...
Aug 31, 2026 at 5:39 PM
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta CAR T cell and in vivo CAR T therapies for autoimmune diseases, hematologic malignancies and solid tumors, today announced it granted an inducement award on August 31, 2026. One individual was hired by Adicet in August 2026 and granted new hire non-qualified stock options to purchase 1,500 shares of Adicet’s common stock with an exercis...
Aug 31, 2026 at 4:01 PM
Definium Therapeutics Announces New Employee Inducement Grants
NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to three newly hired non-executive employees consisting of options to purchase an aggregate of 88,900 common shares of the Company (the "Options") with effective grant dates of August 31, 20...
Aug 31, 2026 at 12:38 PM
Samos Energy Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing August 31, 2026
NEW YORK--(BUSINESS WIRE)--Samos Energy Acquisition Corporation (NYSE: SAMO.U) (the “Company”) announced that, commencing August 31, 2026, holders of the units sold in the Company’s initial public offering may elect to separately trade the Class A ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on the New York Stock Exc...
Aug 28, 2026 at 4:00 PM
Safi Silver Issues Final Tranche of Shares for the Silver Hill Project
TORONTO--(BUSINESS WIRE)--Safi Silver Corp. (TSX-V: SF, OTCPK: PNTZF) (“Safi Silver” or the “Company”) announces that it has issued an aggregate number of 625,000 common shares at a deemed value of $0.40 per Safi Silver share (the “Second Share Issuance”) to the vendors of the Silver Hill project in Morocco (“Silver Hill” or the “Project”) pursuant to the share purchase agreement dated May 25, 2020 between the Company and the vendors (please see the Company’s press release dated September 24, 2...
Aug 28, 2026 at 7:30 AM
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AUSTIN, Texas--(BUSINESS WIRE)--Faeth Therapeutics, Inc. (Nasdaq: FTH) today announced that the Compensation Committee of Faeth’s Board of Directors granted three new employees options to purchase an aggregate of 94,000 shares of the Company’s common stock in connection with their employment (collectively, the “Option Awards”). The Option Awards were granted effective August 25, 2026, pursuant to the Company’s 2026 Inducement Plan as a material inducement to the individuals entering employment...
Aug 27, 2026 at 12:00 PM
ABL Diagnostics: Information Relating to the Total Number of Voting Rights and the Number of Shares Constituting the Share Capital
WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics: (Paris:ABLD) Date Total Number of Shares Constituting the Share Capital Number of Voting Rights (1) (2) Theoretical Voting Rights Exercisable Voting Rights August 12, 2026 16 114 656 30.501.420 30.471.564 (1) Theoretical voting rights are calculated on the basis of all shares to which voting rights are attached, including shares for which voting rights have been suspended or deprived. (2) In accordance with the resolutions adopt...
Aug 26, 2026 at 4:15 PM
Unum Group’s Board of Directors Authorizes $1 Billion Share Repurchase Program
CHATTANOOGA, Tenn.--(BUSINESS WIRE)--Unum Group (NYSE: UNM) announced today that its board of directors has approved a new share repurchase program authorizing the company to repurchase up to $1 billion of its common stock from time to time beginning on September 1, 2026. The company’s current share repurchase program will continue in effect through August 31, 2026, at which time the current program will terminate and all subsequent repurchases will take place under the new program. The timing...
Aug 26, 2026 at 4:05 PM
Chiron Real Estate Inc. Announces Employee Inducement Awards Under NYSE Rule 303A.08
BETHESDA, Md.--(BUSINESS WIRE)--Chiron Real Estate Inc. (NYSE: XRN) (the "Company" or "Chiron") today announced that it granted employment inducement awards to three executive officers who joined the Company in 2026.The awards will be issued on August 27, 2026 and, as previously approved in connection with each executive's commencement of employment with Chiron and as a material inducement to acceptance of employment with the Company, will consist of an aggregate of 80,000 stock options granted...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.